Hypertension case finding and optimal management and lipid optimal management
To allow for interventions to optimise blood pressure and minimise the risk of myocardial infarction and stroke.
Use the dropdowns on this page to see NICE guidance mapped to the main aim for this clinical area.
Cardiovascular disease: identifying and supporting people most at risk of dying early (PH15) aims to reduce the number of people who are disadvantaged, dying prematurely by ensuring people have better access to flexible, well-coordinated treatment and support.
Hypertension in adults: diagnosis and management (NG136) covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes.
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238) covers identifying and assessing risk of cardiovascular disease (CVD) in adults without established CVD. It covers lifestyle changes and lipid-lowering treatment (including statins) for primary and secondary prevention of CVD, and includes guidance for people who also have diabetes or chronic kidney disease.
Hypertension in adults (QS28) covers managing hypertension in adults. It includes diagnosis and investigations, treatment and specialist referral.
Cardiovascular disease and lipid modification (QS100) covers identifying and assessing cardiovascular risk in adults and treatment to prevent cardiovascular disease.
Tools to help put our guidance into practice
Hypertension in adults: diagnosis and treatment - a 2-page visual summary on the recommendations for diagnosing and treating hypertension.
How do I control my blood pressure? Lifestyle options and choice of medicines - Patient decision aid and user guide and data sources.
Taking a statin to reduce the risk of coronary heart disease and stroke: a patient decision aid.
Hypertension in adults: diagnosis and management (NG136) baseline assessment template can be used to evaluate current practice and plan actions to meet the recommendations.
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238) baseline assessment template can be used to evaluate current practice and plan actions to meet the recommendations.
Hypertension in adults (QS28) Quality standard service improvement template helps providers make an initial assessment of their service compared with a selection of quality statements, recording an action pklan and monitoring quality improvement over time.
Cardiovascular risk assessment and lipid modification (QS100) Quality standard service improvement template helps providers make an initial assessment of their service compared with a selection of quality statements, recording an action plan and monitoring quality improvement over time.
Resource impact report and template associated with Hypertension in adults: diagnosis and management (NG136) may be helpful with business case development / costings.
Further resources
NICE Clinical Knowledge Summaries (CKS) - hypertension provide primary care practitioners with a readily accessible summary of the current evidence base and practical guidance on best practice.
Read our recommendations for research on Hypertension in adults (NG136): diagnosis and management
NICE-endorsed resources
NHS England Statin intolerance pathway brings together multiple NICE guidance and technology appraisals into a single document, to support a consistent approach to the management of statin intolerance.
NHS England Lipid management national treatment algorithm and pathway - a summary of national guidance for lipid management for primary and secondary prevention of cardiovascular disease (CVD).